8/14/2019 Power Point Pharma)

1/35

IND IAN PHARMACEUT ICAL

INSDUSTRY

8/14/2019 Power Point Pharma)

2/35

TEAMMEMBERS1.MANOJ GADE

2.JASPREET SINGH SASAN

3.GOPAL AGARWAL

4.ASHIT KUMAR

5.RAJESH AGARWAL

6.RAVI SAHARE

8/14/2019 Power Point Pharma)

3/35

MEDICAL SCIENCE

AYURVEDA UNANI HOMEOPATHY ALLOPATHY

http://www.sunmediaonline.com/indiachronicle/nov07/ic_images/invest/parma.jpghttp://www.inmagine.com/emo015/emo015015-photo

8/14/2019 Power Point Pharma)

4/35

INDIAN PHARMACEUTICAL INDUSTRY :HISTORY

1. BENGAL CHEMICALS AND PHARMACEUTICAL

WORKS

2. GOVERONMENT POLICIES

3. PRODUCT PATENT ACT 1970

8/14/2019 Power Point Pharma)

5/35

http://images.google.co.in/imgres?imgurl=http://musicodobrasil.com.br/loronixcontent/capasloronix/L/mendezchallengepost-image017.jpg&imgrefurl=http://loronix.blogspot.com/2007_11_04_archive.html&h=343&w=550&sz=117&hl=en&start=7&um=1&tbnid=TxDFr9vZZj42WM:&tbnh=83&tbnw=133&prev=/images%3Fq%3DCARTOONS%2BON%2BCHALLENGES%26um%3D1%26hl%3Den

8/14/2019 Power Point Pharma)

6/35

CURRENTSCENARIO

FDI

TURNOVERGOVERONMENTPOLICIES

CHALLENGES

EMPLOYMENT

http://images.google.co.in/imgres?imgurl=http://musicodobrasil.com.br/loronixcontent/capasloronix/L/mendezchallengepost-image017.jpg&imgrefurl=http://loronix.blogspot.com/2007_11_04_archive.html&h=343&w=550&sz=117&hl=en&start=7&um=1&tbnid=TxDFr9vZZj42WM:&tbnh=83&tbnw=133&prev=/images%3Fq%3DCARTOONS%2BON%2BCHALLENGES%26um%3D1%26hl%3Denhttp://images.google.co.in/imgres?imgurl=http://www.piperreport.com/archives/images/Challenges%2520to%2520Pharma%2520Industry.jpg&imgrefurl=http://www.piperreport.com/archives/categories/9.html&h=600&w=800&sz=533&hl=en&start=6&um=1&tbnid=SQuLmnBJJgSV3M:&tbnh=107&tbnw=143&prev=/images%3Fq%3DCARTOONS%2BON%2BPHARMA%2BTURNOVER%26um%3D1%26hl%3Den

8/14/2019 Power Point Pharma)

7/35

ADVANTAGEINDIACOMPETENT

WORKFORCE

COST EFFECTIVECHEMICAL SYSNTHESIS

GLOBALIZATION

LEGAL & FINANCIALFRAMEWORK

INFORMATION TECH.

http://images.google.co.in/imgres?imgurl=http://www.marklebuilding.com/images/workforce_body.jpg&imgrefurl=http://www.marklebuilding.com/workforce.htm&h=379&w=550&sz=21&hl=en&start=16&um=1&tbnid=WVlu8yG3XDtLJM:&tbnh=92&tbnw=133&prev=/images%3Fq%3DPICTURES%2BOF%2BWORKFORCE%26um%3D1%26hl%3Denhttp://images.google.co.in/imgres?imgurl=http://content.answers.com/main/content/wp/en/8/82/IndiaLocation.png&imgrefurl=http://www.answers.com/topic/india&h=628&w=1357&sz=48&hl=en&start=74&um=1&tbnid=hzzJ0f2-0XVjJM:&tbnh=69&tbnw=150&prev=/images%3Fq%3DPICTURES%2BOF%2BINDIA%26start%3D60%26ndsp%3D20%26um%3D1%26hl%3Den%26sa%3DN

8/14/2019 Power Point Pharma)

8/35

CLASSIFICATION OF PHARMA INDUSTRY

ON THE BASIS OF

MANAGEMENT

ON THE BASIS OF

PRODUCT MANUFACTURE

ORGANISED UNORGANISED

MNCS INDIAN

BULK DRUGS FORMULATION

PRESCIPTION MEDICINES

OTC MEDICINES

BRANDED GENERICS

8/14/2019 Power Point Pharma)

9/35

Top10Pharmaceuticalsin India, 2008

Rank Company Revenue 2008

(Rs crore)

Revenue 2008

(USD millions)

1 Ranbaxy 4,461 1,026

2 Dr. Reddy's Laboratories 1,933 444

3 Cipla 1,842 423

4 Ashwin Dalvi India 1,387 319

5 Aurobindo Pharma 1,260 290

6 GlaxoSmithKline 1,228 282

7 Sun Pharmaceutical Industries Mar 20072,375 550

8 Cadila Healthcare 1,091 251

9 Wockhardt 980 225

10 allergan 1,110 255

11 Biochem Pharmaceutical 1,091 251

10 aventis 980 225 USD 1 = Rs 40.5Source: Pharmaceutical

Sales Busters, India

Business Insi ht 31-Dec-

Top Players in Indian Pharma Industry

http://en.wikipedia.org/wiki/Ranbaxyhttp://en.wikipedia.org/wiki/Dr._Reddy's_Laboratorieshttp://en.wikipedia.org/wiki/Ciplahttp://en.wikipedia.org/w/index.php?title=Ashwin_Dalvi_India&action=edit&redlink=1http://en.wikipedia.org/w/index.php?title=Aurobindo_Pharma&action=edit&redlink=1http://en.wikipedia.org/wiki/GlaxoSmithKlinehttp://en.wikipedia.org/w/index.php?title=Sun_Pharmaceutical_Industries_Mar_2007&action=edit&redlink=1http://en.wikipedia.org/wiki/Cadila_Healthcarehttp://en.wikipedia.org/w/index.php?title=Wockhardt&action=edit&redlink=1http://en.wikipedia.org/wiki/Allerganhttp://en.wikipedia.org/w/index.php?title=Biochem_Pharmaceutical&action=edit&redlink=1http://en.wikipedia.org/wiki/Aventishttp://en.wikipedia.org/wiki/Aventishttp://en.wikipedia.org/w/index.php?title=Biochem_Pharmaceutical&action=edit&redlink=1http://en.wikipedia.org/wiki/Allerganhttp://en.wikipedia.org/w/index.php?title=Wockhardt&action=edit&redlink=1http://en.wikipedia.org/wiki/Cadila_Healthcarehttp://en.wikipedia.org/w/index.php?title=Sun_Pharmaceutical_Industries_Mar_2007&action=edit&redlink=1http://en.wikipedia.org/wiki/GlaxoSmithKlinehttp://en.wikipedia.org/w/index.php?title=Aurobindo_Pharma&action=edit&redlink=1http://en.wikipedia.org/w/index.php?title=Ashwin_Dalvi_India&action=edit&redlink=1http://en.wikipedia.org/wiki/Ciplahttp://en.wikipedia.org/wiki/Dr._Reddy's_Laboratorieshttp://en.wikipedia.org/wiki/Ranbaxy

8/14/2019 Power Point Pharma)

10/35

Type Public.

Founded 1961

Headquarters Gurgaon, Haryana,India.

Employees 12000 employees of

with 1200 in R&D.

8/14/2019 Power Point Pharma)

11/35

Founded by Ranjit Singh & Gurbax Singhin 1937.

The name RANBAXY came from RANjit &

gurBAX. In 1952 Bhai Mohan Singh bought the

company.

Went public in 1973.

Recently sold to a Japanese company.

8/14/2019 Power Point Pharma)

12/35

Indias largestpharma company.

Exports its product

to 125 countries. Entered U.S.A in

1988.

OTHERS26%

EUROPE17%

China,Brazil,Russia

29%

U.S.A28%

Ranbaxy

8/14/2019 Power Point Pharma)

13/35

June 2008 Daiichi Sankyo took 50.1%stake in RANBAXY for $4.6 Billion.

In 2002 received Economics Times Award

for corporate excellence.Received Indias first approval from

USFDA for AIDS relief.

Member of Million dollar companies.

8/14/2019 Power Point Pharma)

14/35

YEARS 2007 2006 % CHANGE

SALESTURNOVER 39736 34901 13.85

PROFITAFTER TAX

3865 2237 72.75

8/14/2019 Power Point Pharma)

15/35

Revital softgel. Revital tablets.

Garlic pearls. Chericof cough syrup.

Pepfiz. etc

8/14/2019 Power Point Pharma)

16/35

Dr. Reddy's

TypePublic

Founded1984

HeadquartersHyderabad, Andhra Pradesh, India

KeypeopleMr.Anji Reddy, ChairmanMr. GV Prasad, CEO

Mr.Satish Reddy,MD

Employees8,225

REVENUEUS $444 BILLION

http://en.wikipedia.org/wiki/Category:Types_of_companieshttp://en.wikipedia.org/wiki/Public_companyhttp://en.wikipedia.org/wiki/Hyderabad_(India)http://en.wikipedia.org/wiki/Andhra_Pradeshhttp://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/Anji_Reddyhttp://en.wikipedia.org/wiki/GV_Prasadhttp://en.wikipedia.org/wiki/Employmenthttp://en.wikipedia.org/wiki/Employmenthttp://en.wikipedia.org/wiki/GV_Prasadhttp://en.wikipedia.org/wiki/Anji_Reddyhttp://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/Andhra_Pradeshhttp://en.wikipedia.org/wiki/Hyderabad_(India)http://en.wikipedia.org/wiki/Public_companyhttp://en.wikipedia.org/wiki/Category:Types_of_companies

8/14/2019 Power Point Pharma)

17/35

HISTORY

WORK PRINCIPLE

BRANDS

ACHIEVEMENTS

8/14/2019 Power Point Pharma)

18/35

Cadila Healthcare Limited

TypePublic

Founded1952

HeadquartersAhmadabad, India

KeypeopleMR.Pankaj Patel, Chairman

Employees4000

Websitehttp://www.zyduscadila.com/

http://en.wikipedia.org/wiki/Category:Types_of_companieshttp://en.wikipedia.org/wiki/Public_companyhttp://en.wikipedia.org/wiki/1954http://en.wikipedia.org/wiki/Ahmedabadhttp://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/w/index.php?title=Pankaj_Patel&action=edit&redlink=1http://en.wikipedia.org/wiki/Employmenthttp://en.wikipedia.org/wiki/Websitehttp://www.zyduscadila.com/http://www.zyduscadila.com/http://en.wikipedia.org/wiki/Websitehttp://en.wikipedia.org/wiki/Employmenthttp://en.wikipedia.org/w/index.php?title=Pankaj_Patel&action=edit&redlink=1http://en.wikipedia.org/wiki/Indiahttp://en.wikipedia.org/wiki/Ahmedabadhttp://en.wikipedia.org/wiki/1954http://en.wikipedia.org/wiki/Public_companyhttp://en.wikipedia.org/wiki/Category:Types_of_companies

8/14/2019 Power Point Pharma)

19/35

HISTORY

WORK PRINCIPLE

BRANDS

AQUISITION

8/14/2019 Power Point Pharma)

20/35

8/14/2019 Power Point Pharma)

21/35

Established in 1978.

has its two subsidiarycompanies.

Kiran mazumder shaw isthe CEO.

Specializing inBiopharmacuetical,Custom research, clinicalresearch, & Enzymes.

Biocon

Syngeneinternational

Pvt ltd

Clinigeneinternational

Pvt ltd

8/14/2019 Power Point Pharma)

22/35

. Biocon acquires a 70% stake in Germanpharmaceutical company, AxiCorp

Unilever agrees to sell its shareholding inBiocon to the Indian promoters.

Biocon and Abu Dhabi basedpharmaceutical company Neopharma signan MOU to establish a JV to manufacture andmarket a range of biopharmaceuticals forthe GCC countries.

8/14/2019 Power Point Pharma)

23/35

First Indian biotech company to receive US funding forproprietary technologies.

Receive ISO 9001 certification from RWTUV,Germany.

first Indian company to be approved by US FDA for themanufacture of lovastatin, a cholesterol-lowering molecule.

Biocon launches India's first anti-cancer drug BIOMAbEGFR.

8/14/2019 Power Point Pharma)

24/35

Anti- diabetic agentsAnti-hypertensive agentsAnti-inflammatory agents

AntioxidantsCardiovascular agentsDigestive aid enzymes

NutraceuticalsHaemostatic agents

8/14/2019 Power Point Pharma)

25/35

8/14/2019 Power Point Pharma)

26/35

In 1935, K.A.Hamied set up The Chemical, Industrial &Pharmaceutical Laboratories, which came to be popularly known

as Cipla.

In 1968 Cipla manufactures ampicillin for the first time in the

country.

In 1980 Wins Chemexcil Award for Excellence for exports.

Cipla wins National Award for Successful Commercialisation of

Publicly Funded R&D in 1988

Cipla became the first company, outside the USA and Europe to

launch CFC-free inhalers in 2000.

8/14/2019 Power Point Pharma)

27/35

PrescriptionAnimal Product

OTC

Bulk Drugs

Flavors & Fragrances

Agrochemicals

Technology

http://images.google.co.in/imgres?imgurl=http://musicodobrasil.com.br/loronixcontent/capasloronix/L/mendezchallengepost-image017.jpg&imgrefurl=http://loronix.blogspot.com/2007_11_04_archive.html&h=343&w=550&sz=117&hl=en&start=7&um=1&tbnid=TxDFr9vZZj42WM:&tbnh=83&tbnw=133&prev=/images%3Fq%3DCARTOONS%2BON%2BCHALLENGES%26um%3D1%26hl%3Den

8/14/2019 Power Point Pharma)

28/35

FUTURESCENARIO

CRO

DRUG DISCOVERY

PROJECTATTRACTIVEDESTINATION

GOVERNMENT POLICIES

DOMESTIC PHARMAINDUSTRIES

http://images.google.co.in/imgres?imgurl=http://musicodobrasil.com.br/loronixcontent/capasloronix/L/mendezchallengepost-image017.jpg&imgrefurl=http://loronix.blogspot.com/2007_11_04_archive.html&h=343&w=550&sz=117&hl=en&start=7&um=1&tbnid=TxDFr9vZZj42WM:&tbnh=83&tbnw=133&prev=/images%3Fq%3DCARTOONS%2BON%2BCHALLENGES%26um%3D1%26hl%3Denhttp://images.google.co.in/imgres?imgurl=http://www.piperreport.com/archives/images/Challenges%2520to%2520Pharma%2520Industry.jpg&imgrefurl=http://www.piperreport.com/archives/categories/9.html&h=600&w=800&sz=533&hl=en&start=6&um=1&tbnid=SQuLmnBJJgSV3M:&tbnh=107&tbnw=143&prev=/images%3Fq%3DCARTOONS%2BON%2BPHARMA%2BTURNOVER%26um%3D1%26hl%3Den

8/14/2019 Power Point Pharma)

29/35

8/14/2019 Power Point Pharma)

30/35

Strengths

1. Cost effective technology

2. Strong and well-developed manufacturing base

3. Clinical research and trials

4. Knowledge based, low- cost manpower in science & technology

5. High-quality formulations and drugs

6. High standards of purity

7. World-class process development labs

8. Excellent clinical trial centers

8/14/2019 Power Point Pharma)

31/35

2. Low Indian share in world pharmaceutical market (about 2%)

1. Lack of strategic planning

3. Fragmented capacities4. Low R&D investments

5. Absence of association between institutes and industry

6. Low healthcare expenditure

7. Production of duplicate drugs

8/14/2019 Power Point Pharma)

32/35

Opportunities

1. Incredible export potential

2. Increasing health consciousness

3. New innovative therapeutic products

4. Globalization

5. Drug delivery system management

6. Increased incomes

7. Production of generic drugs

8. Contract manufacturing

9. Clinical trials & research

10. Drug molecules

8/14/2019 Power Point Pharma)

33/35

8/14/2019 Power Point Pharma)

34/35

JOB OPPORTUNITIES IN PHARMA SECTOR

PHARMACIST DRUG TERRAPIST HOSPITAL DRUG COORDINATOR

HEALTH INSPECTOR PREPARING PRESCRIPTION FOR PATIENT DRUG INSPECTOR CHEMICAL/ DRUG TECHNICIAN RESEARCH OFFICER PATHOLOGICAL LAB R&D SCIENTIST BIOTECH INDUSTRIES

8/14/2019 Power Point Pharma)

35/35

REFRENCES & WEBLIOGRRAPHREFRENCES & WEBLIOGRRAPH

1) ANNUAL PROJECT REPORT MR. GOPAL AGARWAL (MMS-2001-02)

2) INTERNATIONAL BUSINESS STRATEGIES.COM

3) MARKETRESEARCH.COM

4) PHARMACEUTICAL-DRUG-MANUFACTURERS.COM

5) NAUKRI HUB.COM

6) LEADDISCOVERY .CO.UK

7) ILOVEINDIA.COM